SCHOTT PHARMA INH O.N./ DE000A3ENQ51 /
| 2024-11-08 7:57:00 AM | Chg. -0.6000 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 28.7400EUR | -2.04% | - Turnover: - |
29.0400Bid Size: 300 | 29.3800Ask Size: 300 | 4.39 bill.EUR | 0.51% | 28.89 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 1.01 EUR | - |
| EPS Diluted: | - EUR | - |
| Revenues per Share: | 5.97 EUR | - |
| Book Value per Share: | 4.58 EUR | - |
| Cash Flow per Share: | 1.21 EUR | - |
| Dividend per Share: | 0.15 EUR | - |
| Total | in mill. | |
| Revenues: | 898.60 EUR | - |
| Net Income: | 151.84 EUR | - |
| Operating Cash Flow: | 181.65 EUR | - |
| Cash and Cash Equivalents: | 24.35 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 28.89 | 31.33 |
| P/S Ratio: | 4.89 | 5.30 |
| P/BV ratio: | 6.37 | 6.90 |
| P/CF Ratio: | 24.19 | 26.23 |
| PEG: | - | - |
| Earnings Yield: | 3.46% | 3.19% |
| Dividend Yield: | 0.51% | 0.47% |
| Market Capitalization | ||
| Market Capitalization: | 4.39 bill. EUR | 4.77 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 945,963.3448 EUR | 1.03 mill. EUR |
| Shares Outstanding: | 150.62 mill. | |
Profitability
| Gross Profit Margin: | 35.22% |
| EBIT Margin: | 21.41% |
| Net Profit Margin: | 16.90% |
| Return on Equity: | 21.99% |
| Return on Assets: | 12.33% |
Financial Strength
| Liquidity I / Cash Ratio: | 6.93% |
| Liquidity II / Quick Ratio: | 51.55% |
| Liquidity III / Current Ratio: | 133.37% |
| Debt / Equity Ratio: | 78.41% |
| Dynam. Debt / Equity Ratio: | 298.04% |
Efficiency
| Employees: | 4,646 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 193,413.69 EUR |
| Net Income / Employee: | 32,681.88 EUR |
| Total Assets / Employee: | 265,135.60 EUR |
| * Fiscal Year End: | 2023-09-30 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
